Generation of cytotoxic effector cells against human melanoma. [electronic resource]
- Cancer immunology, immunotherapy : CII Jun 1995
- 397-409 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0340-7004
10.1007/BF01525391 doi
Adult Aged Cell Division--drug effects Cytotoxicity, Immunologic Dose-Response Relationship, Drug Female HLA Antigens--genetics Histocompatibility Antigens Class I--analysis Histocompatibility Antigens Class II--analysis Humans Immunization Immunotherapy, Adoptive Interleukin-2--pharmacology Lymph Nodes--drug effects Lymphatic Metastasis Lymphocytes, Tumor-Infiltrating--drug effects Male Melanoma--immunology Middle Aged Phenotype Recombinant Proteins--pharmacology Sensitivity and Specificity T-Lymphocytes, Cytotoxic--drug effects